CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: AUTOIMMUNE DISEASE TESTING MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Instruments
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Consumables And Kits
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: AUTOIMMUNE DISEASE TESTING MARKET, BY DISEASE TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Disease Type
5.2. Rheumatoid Arthritis
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Systemic Lupus Erythematous
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Scleroderma
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Vasculitis
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Inflammatory Bowel Disease
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Others
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
CHAPTER 6: AUTOIMMUNE DISEASE TESTING MARKET, BY TEST TYPE
6.1. Market Overview
6.1.1 Market Size and Forecast, By Test Type
6.2. Antibodies And Immunolgic Test
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Inflammatory Markers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Routine Laboratory Tests
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Anti-Thyroglobulin Antibody
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: AUTOIMMUNE DISEASE TESTING MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Hospitals And Clinics
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Others
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
CHAPTER 8: AUTOIMMUNE DISEASE TESTING MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product Type
8.2.3. Market Size and Forecast, By Disease Type
8.2.4. Market Size and Forecast, By Test Type
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Autoimmune Disease Testing Market
8.2.7.1. Market Size and Forecast, By Product Type
8.2.7.2. Market Size and Forecast, By Disease Type
8.2.7.3. Market Size and Forecast, By Test Type
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Autoimmune Disease Testing Market
8.2.8.1. Market Size and Forecast, By Product Type
8.2.8.2. Market Size and Forecast, By Disease Type
8.2.8.3. Market Size and Forecast, By Test Type
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Autoimmune Disease Testing Market
8.2.9.1. Market Size and Forecast, By Product Type
8.2.9.2. Market Size and Forecast, By Disease Type
8.2.9.3. Market Size and Forecast, By Test Type
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product Type
8.3.3. Market Size and Forecast, By Disease Type
8.3.4. Market Size and Forecast, By Test Type
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. Germany Autoimmune Disease Testing Market
8.3.7.1. Market Size and Forecast, By Product Type
8.3.7.2. Market Size and Forecast, By Disease Type
8.3.7.3. Market Size and Forecast, By Test Type
8.3.7.4. Market Size and Forecast, By End User
8.3.8. France Autoimmune Disease Testing Market
8.3.8.1. Market Size and Forecast, By Product Type
8.3.8.2. Market Size and Forecast, By Disease Type
8.3.8.3. Market Size and Forecast, By Test Type
8.3.8.4. Market Size and Forecast, By End User
8.3.9. UK Autoimmune Disease Testing Market
8.3.9.1. Market Size and Forecast, By Product Type
8.3.9.2. Market Size and Forecast, By Disease Type
8.3.9.3. Market Size and Forecast, By Test Type
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Italy Autoimmune Disease Testing Market
8.3.10.1. Market Size and Forecast, By Product Type
8.3.10.2. Market Size and Forecast, By Disease Type
8.3.10.3. Market Size and Forecast, By Test Type
8.3.10.4. Market Size and Forecast, By End User
8.3.11. Spain Autoimmune Disease Testing Market
8.3.11.1. Market Size and Forecast, By Product Type
8.3.11.2. Market Size and Forecast, By Disease Type
8.3.11.3. Market Size and Forecast, By Test Type
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest of Europe Autoimmune Disease Testing Market
8.3.12.1. Market Size and Forecast, By Product Type
8.3.12.2. Market Size and Forecast, By Disease Type
8.3.12.3. Market Size and Forecast, By Test Type
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product Type
8.4.3. Market Size and Forecast, By Disease Type
8.4.4. Market Size and Forecast, By Test Type
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. Japan Autoimmune Disease Testing Market
8.4.7.1. Market Size and Forecast, By Product Type
8.4.7.2. Market Size and Forecast, By Disease Type
8.4.7.3. Market Size and Forecast, By Test Type
8.4.7.4. Market Size and Forecast, By End User
8.4.8. China Autoimmune Disease Testing Market
8.4.8.1. Market Size and Forecast, By Product Type
8.4.8.2. Market Size and Forecast, By Disease Type
8.4.8.3. Market Size and Forecast, By Test Type
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Autoimmune Disease Testing Market
8.4.9.1. Market Size and Forecast, By Product Type
8.4.9.2. Market Size and Forecast, By Disease Type
8.4.9.3. Market Size and Forecast, By Test Type
8.4.9.4. Market Size and Forecast, By End User
8.4.10. Australia Autoimmune Disease Testing Market
8.4.10.1. Market Size and Forecast, By Product Type
8.4.10.2. Market Size and Forecast, By Disease Type
8.4.10.3. Market Size and Forecast, By Test Type
8.4.10.4. Market Size and Forecast, By End User
8.4.11. South Korea Autoimmune Disease Testing Market
8.4.11.1. Market Size and Forecast, By Product Type
8.4.11.2. Market Size and Forecast, By Disease Type
8.4.11.3. Market Size and Forecast, By Test Type
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Autoimmune Disease Testing Market
8.4.12.1. Market Size and Forecast, By Product Type
8.4.12.2. Market Size and Forecast, By Disease Type
8.4.12.3. Market Size and Forecast, By Test Type
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product Type
8.5.3. Market Size and Forecast, By Disease Type
8.5.4. Market Size and Forecast, By Test Type
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Autoimmune Disease Testing Market
8.5.7.1. Market Size and Forecast, By Product Type
8.5.7.2. Market Size and Forecast, By Disease Type
8.5.7.3. Market Size and Forecast, By Test Type
8.5.7.4. Market Size and Forecast, By End User
8.5.8. Saudi Arabia Autoimmune Disease Testing Market
8.5.8.1. Market Size and Forecast, By Product Type
8.5.8.2. Market Size and Forecast, By Disease Type
8.5.8.3. Market Size and Forecast, By Test Type
8.5.8.4. Market Size and Forecast, By End User
8.5.9. South Africa Autoimmune Disease Testing Market
8.5.9.1. Market Size and Forecast, By Product Type
8.5.9.2. Market Size and Forecast, By Disease Type
8.5.9.3. Market Size and Forecast, By Test Type
8.5.9.4. Market Size and Forecast, By End User
8.5.10. Rest of LAMEA Autoimmune Disease Testing Market
8.5.10.1. Market Size and Forecast, By Product Type
8.5.10.2. Market Size and Forecast, By Disease Type
8.5.10.3. Market Size and Forecast, By Test Type
8.5.10.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. F. Hoffmann-La Roche Ltd
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Siemens
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Thermo Fisher Scientific Inc.
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Quest Diagnostics
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Abbott
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Werfen, S.A.
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. Trinity Biotech
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. Bio-Rad Laboratories, Inc.
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Grifols, S.A.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Exagen Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 2. Autoimmune Disease Testing Market for Instruments, by Region, 2024 - 2033 ($Billion)
Table 3. Autoimmune Disease Testing Market for Consumables and Kits, by Region, 2024 - 2033 ($Billion)
Table 4. Global Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 5. Autoimmune Disease Testing Market for Rheumatoid Arthritis, by Region, 2024 - 2033 ($Billion)
Table 6. Autoimmune Disease Testing Market for Systemic Lupus Erythematous, by Region, 2024 - 2033 ($Billion)
Table 7. Autoimmune Disease Testing Market for Scleroderma, by Region, 2024 - 2033 ($Billion)
Table 8. Autoimmune Disease Testing Market for Vasculitis, by Region, 2024 - 2033 ($Billion)
Table 9. Autoimmune Disease Testing Market for Inflammatory Bowel Disease, by Region, 2024 - 2033 ($Billion)
Table 10. Autoimmune Disease Testing Market for Others, by Region, 2024 - 2033 ($Billion)
Table 11. Global Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 12. Autoimmune Disease Testing Market for Antibodies and Immunolgic Test, by Region, 2024 - 2033 ($Billion)
Table 13. Autoimmune Disease Testing Market for Inflammatory Markers, by Region, 2024 - 2033 ($Billion)
Table 14. Autoimmune Disease Testing Market for Routine Laboratory Tests, by Region, 2024 - 2033 ($Billion)
Table 15. Autoimmune Disease Testing Market for Anti-Thyroglobulin Antibody, by Region, 2024 - 2033 ($Billion)
Table 16. Autoimmune Disease Testing Market for Others, by Region, 2024 - 2033 ($Billion)
Table 17. Global Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 18. Autoimmune Disease Testing Market for Hospitals and Clinics, by Region, 2024 - 2033 ($Billion)
Table 19. Autoimmune Disease Testing Market for Clinical Laboratories, by Region, 2024 - 2033 ($Billion)
Table 20. Autoimmune Disease Testing Market for Others, by Region, 2024 - 2033 ($Billion)
Table 21. Autoimmune Disease Testing Market, by Region, 2024 - 2033 ($Billion)
Table 22. North America Autoimmune Disease Testing Market, by Country, 2024 - 2033 ($Billion)
Table 23. North America Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 24. North America Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 25. North America Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 26. North America Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 27. U.S. Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 28. U.S. Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 29. U.S. Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 30. U.S. Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 31. Canada Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 32. Canada Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 33. Canada Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 34. Canada Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 35. Mexico Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 36. Mexico Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 37. Mexico Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 38. Mexico Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 39. Europe Autoimmune Disease Testing Market, by Country, 2024 - 2033 ($Billion)
Table 40. Europe Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 41. Europe Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 42. Europe Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 43. Europe Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 44. Germany Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 45. Germany Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 46. Germany Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 47. Germany Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 48. France Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 49. France Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 50. France Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 51. France Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 52. UK Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 53. UK Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 54. UK Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 55. UK Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 56. Italy Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 57. Italy Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 58. Italy Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 59. Italy Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 60. Spain Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 61. Spain Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 62. Spain Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 63. Spain Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 64. Rest of Europe Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 65. Rest of Europe Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 66. Rest of Europe Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 67. Rest of Europe Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 68. Asia-Pacific Autoimmune Disease Testing Market, by Country, 2024 - 2033 ($Billion)
Table 69. Asia-Pacific Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 70. Asia-Pacific Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 71. Asia-Pacific Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 72. Asia-Pacific Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 73. Japan Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 74. Japan Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 75. Japan Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 76. Japan Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 77. China Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 78. China Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 79. China Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 80. China Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 81. India Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 82. India Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 83. India Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 84. India Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 85. Australia Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 86. Australia Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 87. Australia Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 88. Australia Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 89. South Korea Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 90. South Korea Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 91. South Korea Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 92. South Korea Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 93. Rest of Asia-Pacific Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 94. Rest of Asia-Pacific Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 95. Rest of Asia-Pacific Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 96. Rest of Asia-Pacific Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 97. LAMEA Autoimmune Disease Testing Market, by Country, 2024 - 2033 ($Billion)
Table 98. LAMEA Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 99. LAMEA Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 100. LAMEA Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 101. LAMEA Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 102. Brazil Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 103. Brazil Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 104. Brazil Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 105. Brazil Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 106. Saudi Arabia Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 107. Saudi Arabia Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 108. Saudi Arabia Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 109. Saudi Arabia Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 110. South Africa Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 111. South Africa Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 112. South Africa Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 113. South Africa Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 114. Rest of LAMEA Autoimmune Disease Testing Market, by Product Type, 2024 - 2033 ($Billion)
Table 115. Rest of LAMEA Autoimmune Disease Testing Market, by Disease Type, 2024 - 2033 ($Billion)
Table 116. Rest of LAMEA Autoimmune Disease Testing Market, by Test Type, 2024 - 2033 ($Billion)
Table 117. Rest of LAMEA Autoimmune Disease Testing Market, by End-user, 2024 - 2033 ($Billion)
Table 118. F. Hoffmann-La Roche Ltd.: Key Executives
Table 119. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 120. F. Hoffmann-La Roche Ltd.: Operating Segments
Table 121. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 122. F. Hoffmann-La Roche Ltd.: Key Strategic Moves and Developments
Table 123. Siemens : Key Executives
Table 124. Siemens : Company Snapshot
Table 125. Siemens : Operating Segments
Table 126. Siemens : Product Portfolio
Table 127. Siemens : Key Strategic Moves and Developments
Table 128. Thermo Fisher Scientific Inc.: Key Executives
Table 129. Thermo Fisher Scientific Inc.: Company Snapshot
Table 130. Thermo Fisher Scientific Inc.: Operating Segments
Table 131. Thermo Fisher Scientific Inc.: Product Portfolio
Table 132. Thermo Fisher Scientific Inc.: Key Strategic Moves and Developments
Table 133. Quest Diagnostics: Key Executives
Table 134. Quest Diagnostics: Company Snapshot
Table 135. Quest Diagnostics: Operating Segments
Table 136. Quest Diagnostics: Product Portfolio
Table 137. Quest Diagnostics: Key Strategic Moves and Developments
Table 138. Abbott: Key Executives
Table 139. Abbott: Company Snapshot
Table 140. Abbott: Operating Segments
Table 141. Abbott: Product Portfolio
Table 142. Abbott: Key Strategic Moves and Developments
Table 143. Werfen, SA: Key Executives
Table 144. Werfen, SA: Company Snapshot
Table 145. Werfen, SA: Operating Segments
Table 146. Werfen, SA: Product Portfolio
Table 147. Werfen, SA: Key Strategic Moves and Developments
Table 148. Trinity Biotech: Key Executives
Table 149. Trinity Biotech: Company Snapshot
Table 150. Trinity Biotech: Operating Segments
Table 151. Trinity Biotech: Product Portfolio
Table 152. Trinity Biotech: Key Strategic Moves and Developments
Table 153. Bio-Rad Laboratories, Inc.: Key Executives
Table 154. Bio-Rad Laboratories, Inc.: Company Snapshot
Table 155. Bio-Rad Laboratories, Inc.: Operating Segments
Table 156. Bio-Rad Laboratories, Inc.: Product Portfolio
Table 157. Bio-Rad Laboratories, Inc.: Key Strategic Moves and Developments
Table 158. Grifols, SA : Key Executives
Table 159. Grifols, SA : Company Snapshot
Table 160. Grifols, SA : Operating Segments
Table 161. Grifols, SA : Product Portfolio
Table 162. Grifols, SA : Key Strategic Moves and Developments
Table 163. Exagen Inc.: Key Executives
Table 164. Exagen Inc.: Company Snapshot
Table 165. Exagen Inc.: Operating Segments
Table 166. Exagen Inc.: Product Portfolio
Table 167. Exagen Inc.: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Autoimmune Disease Testing Market, 2024 - 2033
Figure 2. Segmentation of Autoimmune Disease Testing Market, 2024 - 2033
Figure 3. Top Investment Pocket in Autoimmune Disease Testing Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalautoimmune Disease Testing Market
Figure 10. Global Autoimmune Disease Testing Market Segmentation, by Product Type
Figure 11. Autoimmune Disease Testing Market for Instruments, by Country, 2024 - 2033 ($Billion)
Figure 12. Autoimmune Disease Testing Market for Consumables and Kits, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Autoimmune Disease Testing Market Segmentation, by Disease Type
Figure 14. Autoimmune Disease Testing Market for Rheumatoid Arthritis, by Country, 2024 - 2033 ($Billion)
Figure 15. Autoimmune Disease Testing Market for Systemic Lupus Erythematous, by Country, 2024 - 2033 ($Billion)
Figure 16. Autoimmune Disease Testing Market for Scleroderma, by Country, 2024 - 2033 ($Billion)
Figure 17. Autoimmune Disease Testing Market for Vasculitis, by Country, 2024 - 2033 ($Billion)
Figure 18. Autoimmune Disease Testing Market for Inflammatory Bowel Disease, by Country, 2024 - 2033 ($Billion)
Figure 19. Autoimmune Disease Testing Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 20. Global Autoimmune Disease Testing Market Segmentation, by Test Type
Figure 21. Autoimmune Disease Testing Market for Antibodies and Immunolgic Test, by Country, 2024 - 2033 ($Billion)
Figure 22. Autoimmune Disease Testing Market for Inflammatory Markers, by Country, 2024 - 2033 ($Billion)
Figure 23. Autoimmune Disease Testing Market for Routine Laboratory Tests, by Country, 2024 - 2033 ($Billion)
Figure 24. Autoimmune Disease Testing Market for Anti-Thyroglobulin Antibody, by Country, 2024 - 2033 ($Billion)
Figure 25. Autoimmune Disease Testing Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 26. Global Autoimmune Disease Testing Market Segmentation, by End-user
Figure 27. Autoimmune Disease Testing Market for Hospitals and Clinics, by Country, 2024 - 2033 ($Billion)
Figure 28. Autoimmune Disease Testing Market for Clinical Laboratories, by Country, 2024 - 2033 ($Billion)
Figure 29. Autoimmune Disease Testing Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 30. Top Winning Strategies, by Year, 2021-2023*
Figure 31. Top Winning Strategies, by Development, 2021-2023*
Figure 32. Top Winning Strategies, by Company, 2021-2023*
Figure 33. Product Mapping of Top 10 Players
Figure 34. Competitive Dashboard
Figure 35. Competitive Heatmap: Autoimmune Disease Testing Market
Figure 36. Top Player Positioning, 2023
Figure 37. F. Hoffmann-La Roche Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 38. F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 39. F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2023 (%)
Figure 40. Siemens : Net Sales, 2021-2023 ($Billion)
Figure 41. Siemens : Revenue Share, by Segment, 2023 (%)
Figure 42. Siemens : Revenue Share, by Region, 2023 (%)
Figure 43. Thermo Fisher Scientific Inc.: Net Sales, 2021-2023 ($Billion)
Figure 44. Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2023 (%)
Figure 45. Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2023 (%)
Figure 46. Quest Diagnostics: Net Sales, 2021-2023 ($Billion)
Figure 47. Quest Diagnostics: Revenue Share, by Segment, 2023 (%)
Figure 48. Quest Diagnostics: Revenue Share, by Region, 2023 (%)
Figure 49. Abbott: Net Sales, 2021-2023 ($Billion)
Figure 50. Abbott: Revenue Share, by Segment, 2023 (%)
Figure 51. Abbott: Revenue Share, by Region, 2023 (%)
Figure 52. Werfen, SA: Net Sales, 2021-2023 ($Billion)
Figure 53. Werfen, SA: Revenue Share, by Segment, 2023 (%)
Figure 54. Werfen, SA: Revenue Share, by Region, 2023 (%)
Figure 55. Trinity Biotech: Net Sales, 2021-2023 ($Billion)
Figure 56. Trinity Biotech: Revenue Share, by Segment, 2023 (%)
Figure 57. Trinity Biotech: Revenue Share, by Region, 2023 (%)
Figure 58. Bio-Rad Laboratories, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 59. Bio-Rad Laboratories, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 60. Bio-Rad Laboratories, Inc.: Revenue Share, by Region, 2023 (%)
Figure 61. Grifols, SA : Net Sales, 2021-2023 ($Billion)
Figure 62. Grifols, SA : Revenue Share, by Segment, 2023 (%)
Figure 63. Grifols, SA : Revenue Share, by Region, 2023 (%)
Figure 64. Exagen Inc.: Net Sales, 2021-2023 ($Billion)
Figure 65. Exagen Inc.: Revenue Share, by Segment, 2023 (%)
Figure 66. Exagen Inc.: Revenue Share, by Region, 2023 (%)
